AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

75 76 Next >

UK Agency Says AstraZeneca's Breast Cancer Drug Enhertu Is Expensive, CEO Pascal Soriot Urges Review Of Drug Pricing Assessment ↗

July 26, 2024

AstraZeneca CEO Pascal Soriot urges the UK government to reassess drug funding after NICE deems Enhertu too costly, highlighting concerns over new methodology affecting advanced cancer treatments and...

Via Benzinga

3 Surprisingly Underrated Stocks to Buy Right Now ↗

July 26, 2024

These stocks arguably deserve more respect from investors.

Via The Motley Fool

AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance

July 26, 2024

AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.

Via MarketBeat

Topics ETFs

7 Explosive Growth Stocks Set to Soar in 2024 ↗

July 25, 2024

These seven explosive growth stocks across various sectors have the potential to deliver substantial returns for investors in 2024.

Via InvestorPlace

Why AstraZeneca Stock Is Sliding Today ↗

July 25, 2024

The British drugmaker's Q2 results were good, but seemingly not good enough for many investors.

Via The Motley Fool

Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday? ↗

July 25, 2024

Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown.

Via Benzinga

Topics Economy

AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript ↗

July 25, 2024

AZN earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook ↗

July 25, 2024

The company no longer expects its earnings to decline this year. Instead, AstraZeneca called for stable profit.

Via Investor's Business Daily

AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines ↗

July 25, 2024

AstraZeneca's Q2 sales rose 13% to $12.94 billion, beating expectations. Oncology sales grew 15% to $5.33 billion. Notable drug performances include Tagrisso up 8%, Calquence up 21%, and Farxiga up...

Via Benzinga

Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand ↗

July 25, 2024

Sanofi reports a 7.8% YoY sales increase in Q2, with sales reaching $11.57 billion, beating consensus. Key highlights include a 29.2% rise in Dupixent sales and a stable 2024 business EPS forecast.

Via Benzinga

Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House ↗

July 25, 2024

Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech...

Via Benzinga

Topics Government Stocks

AstraZeneca’s H1 and Q2 2024 Financial Results

July 25, 2024

From AstraZeneca

Via Business Wire

AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q2 2024 ↗

July 25, 2024

AZN stock results show that AstraZeneca missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks ↗

July 25, 2024

It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it.

Via InvestorPlace

American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday ↗

July 25, 2024

Via Benzinga

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants ↗

July 23, 2024

Merck shares topline results from its Phase 2b/3 trial of clesrovimab, showing efficacy in reducing RSV-related infections in infants. Clesrovimab met safety and efficacy endpoints.

Via Benzinga

AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife ↗

July 23, 2024

The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market.

Via Benzinga

Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗

July 22, 2024

It was another wild week for the market as it had to contend with a lot of news.

Via Talk Markets

Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst ↗

July 22, 2024

Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinical improvements in communication, cognition, and motor function. Safety...

Via Benzinga

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' ↗

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment ↗

July 17, 2024

European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed.

Via Benzinga

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024 ↗

July 15, 2024

Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market.

Via InvestorPlace

7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns ↗

July 10, 2024

These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.

Via InvestorPlace

United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win ↗

July 05, 2024

New leadership in the United Kingdom could make several sectors standout going forward. Here's what experts are saying after the election.

Via Benzinga

Topics ETFs

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients ↗

July 05, 2024

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.

Via Investor's Business Daily

3 Set-It-and-Forget-It Stocks for Lasting Financial Security ↗

July 02, 2024

Three set-it-and-forget-it stocks powered by consistent growth and sustainable profitability to buy for wealth compounding.

Via InvestorPlace

AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment ↗

July 01, 2024

The European Medicines Agency has accepted AstraZeneca's marketing authorization application for sipavibart, an investigational long-acting antibody for pre-exposure prophylaxis of COVID-19 in...

Via Benzinga

7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗

June 26, 2024

With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.

Via InvestorPlace

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

75 76 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.